rs2234996

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000051.4(ATM):​c.332-71A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0358 in 1,330,594 control chromosomes in the GnomAD database, including 1,091 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 64 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1027 hom. )

Consequence

ATM
NM_000051.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.21

Publications

9 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Laboratory for Molecular Medicine, Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-108235599-A-G is Benign according to our data. Variant chr11-108235599-A-G is described in ClinVar as Benign. ClinVar VariationId is 1179574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0257 (3920/152360) while in subpopulation SAS AF = 0.0476 (230/4834). AF 95% confidence interval is 0.0425. There are 64 homozygotes in GnomAd4. There are 1835 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 64 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATMNM_000051.4 linkc.332-71A>G intron_variant Intron 4 of 62 ENST00000675843.1 NP_000042.3 Q13315A0A024R3C7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATMENST00000675843.1 linkc.332-71A>G intron_variant Intron 4 of 62 NM_000051.4 ENSP00000501606.1 Q13315

Frequencies

GnomAD3 genomes
AF:
0.0258
AC:
3924
AN:
152242
Hom.:
64
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00776
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0213
Gnomad ASJ
AF:
0.0795
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0477
Gnomad FIN
AF:
0.00791
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0378
Gnomad OTH
AF:
0.0320
GnomAD4 exome
AF:
0.0371
AC:
43661
AN:
1178234
Hom.:
1027
AF XY:
0.0372
AC XY:
22030
AN XY:
592146
show subpopulations
African (AFR)
AF:
0.00667
AC:
175
AN:
26246
American (AMR)
AF:
0.0190
AC:
661
AN:
34762
Ashkenazi Jewish (ASJ)
AF:
0.0834
AC:
1991
AN:
23880
East Asian (EAS)
AF:
0.000142
AC:
5
AN:
35122
South Asian (SAS)
AF:
0.0455
AC:
3392
AN:
74474
European-Finnish (FIN)
AF:
0.0110
AC:
493
AN:
44706
Middle Eastern (MID)
AF:
0.0273
AC:
100
AN:
3658
European-Non Finnish (NFE)
AF:
0.0397
AC:
35105
AN:
884990
Other (OTH)
AF:
0.0345
AC:
1739
AN:
50396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2070
4140
6210
8280
10350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1258
2516
3774
5032
6290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0257
AC:
3920
AN:
152360
Hom.:
64
Cov.:
32
AF XY:
0.0246
AC XY:
1835
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00774
AC:
322
AN:
41594
American (AMR)
AF:
0.0212
AC:
324
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0795
AC:
276
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.0476
AC:
230
AN:
4834
European-Finnish (FIN)
AF:
0.00791
AC:
84
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0378
AC:
2574
AN:
68024
Other (OTH)
AF:
0.0312
AC:
66
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
203
406
608
811
1014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0305
Hom.:
61
Bravo
AF:
0.0262
Asia WGS
AF:
0.0210
AC:
72
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.5
DANN
Benign
0.82
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234996; hg19: chr11-108106326; COSMIC: COSV104591951; API